|
1）Jens UM, Peter RG, Andreas T. Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): An emerging field for advanced technologies. J Hepatol. 2012; 56: 267-75
|
|
|
|
2）Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006; 6: 857-66
|
|
|
|
|
|
3）Kumar V, Kato N, Urabe Y, et al. Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat Genet. 2011; 43: 455-8
|
|
|
|
|
|
4）Miki D, Ochi H, Hayes CN, et al. Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers. Nat Genet. 2011; 43: 797-800
|
|
|
|
|
|
5）Egger G, Liang G, Aparicio A, et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004; 429: 457-63
|
|
|
|
|
|
6）Gal-Yam EN, Saito Y, Egger G, et al. Cancer epigenetics: modifications, screening, and therapy. Annu Rev Med. 2008; 59: 267-80
|
|
|
|
|
|
7）Okano M, Xie S, Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet. 1998; 19: 219-20
|
|
|
|
|
|
8）Saito Y, Kanai Y, Nakagawa T, et al. Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer. 2003; 105: 527-32
|
|
|
|
|
|
9）Saito Y, Kanai Y, Sakamoto M, et al. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology. 2001; 33: 561-8
|
|
|
|
|
|
10）Liang G, Lin JC, Wei V, et al. Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. Proc Natl Acad Sci U S A. 2004; 101: 7357-62
|
|
|
|
|
|
11）Kouzarides T. Chromatin modifications and their function. Cell. 2007; 128: 693-705
|
|
|
|
|
|
12）Jenuwein T, Allis CD. Translating the histone code. Science. 2001; 293: 1074-80
|
|
|
|
|
|
13）Kondo Y, Shen L, Cheng AS, et al. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet. 2008; 40: 741-50
|
|
|
|
|
|
14）Cai MY, Hou JH, Rao HL, et al. High expression of H3K27me3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts worse prognosis in patients. Mol Med. 2011; 17: 12-20
|
|
|
|
|
|
15）Wu LM, Yang Z, Zhou L, et al. Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma. PLoS One. 2010; 5: e14460
|
|
|
|
|
|
16）Su H, Yang JR, Xu T, et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 2009; 69: 1135-42
|
|
|
|
|
|
17）Jopling CL, Yi M, Lancaster AM, et al. Modulation of hepatitis C virus RNA abundance by a liverspecific MicroRNA. Science. 2005; 309: 1577-81
|
|
|
|
|
|
18）Fornari F, Gramantieri L, Giovannini C, et al. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 2009; 69: 5761-7
|
|
|
|
|
|
19）Bai S, Nasser MW, Wang B, et al. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem. 2009; 284: 32015-27
|
|
|
|
|
|
20）Tsai WC, Hsu PW, Lai TC, et al. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology. 2009; 49: 1571-82
|
|
|
|
|
|
21）Dai R, Li J, Liu Y, et al. miR-221/222 suppression protects against endoplasmic reticulum stress-induced apoptosis via p27 (Kip1)- and MEK/ERK-mediated cell cycle regulation. Biol Chem. 2010; 391: 791-801
|
|
|
|
|
|
22）Fornari F, Gramantieri L, Ferracin M, et al. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene. 2008; 27: 5651-61
|
|
|
|
|
|
23）Datta J, Kutay H, Nasser MW, et al. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res. 2008; 68: 5049-58
|
|
|
|
|
|
24）Furuta M, Kozaki KI, Tanaka S, et al. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis. 2010; 31: 766-76
|
|
|
|
|
|
25）Zhang S, Shan C, Kong G, et al. MicroRNA520e suppresses growth of hepatoma cells by targeting the NF-kappaB-inducing kinase (NIK). Oncogene. 2012; 31: 3607-20
|
|
|
|
|
|
26）Fabbri M, Garzon R, Cimmino A, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A. 2007; 104: 15805-10
|
|
|
|
|
|
27）Huang J, Wang Y, Guo Y, et al. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology. 2010; 52: 60-70
|
|
|
|
|